Unitedhealth Group INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Dennis Andrew Stankiewicz, Chief Accounting Officer of Unitedhealth Group Inc, reported a transaction in 233 shares of common stock on August 11, 2026.
NYSE
Patrick Hugh Conway, Chief Executive Officer, Optum of Unitedhealth Group Inc, sold 500 shares of common stock on August 5, 2026 for $410.00 per share.
NYSE
John H. Noseworthy, a Director at UnitedHealth Group, acquired 206 deferred stock units as part of his regular quarterly compensation.
NYSE
Valerie Montgomery Rice, a Director at UnitedHealth Group, received 220 deferred stock units as compensation for her services.
NYSE
Frederick William McNabb III, a Director at UnitedHealth Group, acquired 250 deferred stock units as part of his quarterly compensation.
NYSE
Scott Gottlieb, a Director at UnitedHealth Group, acquired 210 shares of common stock through deferred stock units as part of his quarterly compensation.
NYSE
Kristen Gil, a Director at UnitedHealth Group, acquired 206 deferred stock units as part of her quarterly compensation.
NYSE
Paul R. Garcia, a Director at UnitedHealth Group, reported transactions involving the acquisition of common stock and deferred stock units.
NYSE
Timothy Patrick Flynn, a Director at UnitedHealth Group, acquired deferred stock units as part of his quarterly compensation.
NYSE
Charles D. Baker, a Director at UnitedHealth Group, acquired 220 deferred stock units on July 1, 2026, as part of his regular quarterly compensation.
NYSE
Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reported a transaction involving common stock, acquiring dividend equivalents on restricted stock units.
NYSE
John H. Noseworthy, a Director at UnitedHealth Group, acquired 41 shares of common stock on June 23, 2026, through dividend equivalents.
NYSE
Paul R. Garcia, a Director at UnitedHealth Group, acquired 13 shares of common stock on June 23, 2026, through dividend equivalents.
NYSE
Valerie Montgomery Rice, a Director at UnitedHealth Group, acquired 41 shares of common stock on June 23, 2026, through dividend equivalents.
NYSE
UnitedHealth Group Director Kristen Gil reported a transaction involving common stock on June 23, 2026.
NYSE
UnitedHealth Group Director Scott Gottlieb acquired 449 shares of common stock on June 23, 2026, through dividend equivalents on vested deferred stock units.
NYSE
Patrick Hugh Conway, Chief Executive Officer of Optum at UnitedHealth Group, reported a transaction involving the acquisition of common stock.
NYSE
Timothy J. Noel, Chief Executive Officer of UHC, acquired 76.063 shares of common stock in UnitedHealth Group.
NYSE
Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reported transactions involving common stock and dividend equivalents.
NYSE
UnitedHealth Group Chief Financial Officer Wayne S. DeVeydt acquired 111.76 shares of common stock on June 23, 2026, through dividend equivalents.
NYSE
Stephen J. Hemsley, CEO of UnitedHealth Group, reported transactions involving common stock and dividend equivalents, including transfers between direct holdings and trusts.
NYSE
Dennis Stankiewicz, Chief Accounting Officer at UnitedHealth Group, acquired 50.59 shares of common stock through dividend equivalents on June 23, 2026.
NYSE
Charles D. Baker, a Director at UnitedHealth Group, acquired 13 shares of common stock through dividend equivalents on June 23, 2026.
NYSE
Frederick William McNabb III, a Director at UnitedHealth Group, acquired 50 shares of common stock on June 23, 2026, through dividend equivalents.
NYSE
Timothy Patrick Flynn, a Director at UnitedHealth Group Inc., acquired 61 shares of common stock on June 23, 2026.
NYSE
Patrick H. Conway, CEO of Optum, disposed of 686.861 shares of UnitedHealth Group common stock to cover tax obligations.
NYSE
Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reported a disposition of 134.02 shares of common stock.
NYSE
Patrick H. Conway, CEO of Optum, disposed of 203.821 shares of UnitedHealth Group common stock to cover tax obligations.
NYSE
Patrick H. Conway, CEO of Optum, sold 800 shares of UnitedHealth Group common stock on April 23, 2026.
NYSE
Michele J. Hooper, a Director at UnitedHealth Group, acquired 206 deferred stock units as part of her quarterly compensation.